| Cash Flow | 2025-09-30 |
|---|---|
| Net income | 30,316 |
| Depreciation | 13,077 |
| Amortization of deferred debt issuance costs | 4,107 |
| Amortization | 42,354 |
| Stock-based compensation | 23,352 |
| Deferred income taxes | 2,711 |
| Non-cash adjustments to fair value of contingent consideration liability | 3,504 |
| Loss on early extinguishment of debt | 363 |
| Accounts receivable | -20,310 |
| Inventories | 15,242 |
| Accounts payable | 3,863 |
| Accrued compensation and benefits | 8,990 |
| Other assets | 12,934 |
| Other liabilities | -417 |
| Net cash provided by operating activities | 124,354 |
| Purchases of property, plant and equipment | 14,695 |
| Other | -850 |
| Net cash used in investing activities | -13,845 |
| Payments on term loan | 79,821 |
| Proceeds from term loan | 25,234 |
| Payments on revolving line of credit | 508,432 |
| Proceeds from revolving line of credit | 508,432 |
| Payments to redeem convertible notes | 0 |
| Payments related to contingent consideration | 22,577 |
| Payments related to debt issuance costs | 2,897 |
| Dividends paid on common stock | 18,555 |
| Other, net | 166 |
| Net cash used in financing activities | -98,450 |
| Effect of exchange rate changes on cash and cash equivalents | 2,411 |
| Net increase in cash and cash equivalents | 14,470 |
| Cash and cash equivalents at beginning of period | 24,459 |
| Cash and cash equivalents at end of period | 38,929 |
CONMED Corp (CNMD)
CONMED Corp (CNMD)